Given the detrimental effect of sustained mitochondrial fission in ischemic heart disease, exploring new ways to attenuate Drp1-mediated mitochondrial fission is of clinical interest to combat MIRI. The gene discussed is DNM1L; the disease is coronary artery disorder.